Aoxing Pharmaceutical Company, Inc. (AOXG)
OTCMKTS: AOXG · Delayed Price · USD
0.0071
+0.0027 (61.36%)
Jul 3, 2024, 11:40 AM EDT - Market closed

AOXG Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Year
Current20232022202120202019 2018 - 2007
Market Capitalization
1-----
Upgrade
Market Cap Growth
-92.73%-----
Upgrade
Enterprise Value
21-----
Upgrade
PE Ratio
4.1800000
Upgrade
PS Ratio
0.09-----
Upgrade
PB Ratio
0.0300000
Upgrade
P/FCF Ratio
-1.27-----
Upgrade
P/OCF Ratio
-1.30-----
Upgrade
EV/Sales Ratio
3.72-----
Upgrade
EV/EBITDA Ratio
20.41-----
Upgrade
EV/EBIT Ratio
412.01-----
Upgrade
Debt / EBITDA Ratio
26.71-----
Upgrade
Debt / FCF Ratio
-19.89-----
Upgrade
Asset Turnover
0.0900000
Upgrade
Return on Equity (ROE)
0.62%-----
Upgrade
Return on Assets (ROA)
0.19%-----
Upgrade
Return on Capital (ROIC)
0.84%-----
Upgrade
Earnings Yield
21.75%-----
Upgrade
FCF Yield
-257.60%0.00%0.00%0.00%0.00%0.00%
Upgrade
Buyback Yield / Dilution
-347.73%-----
Upgrade
Total Shareholder Return
-347.73%-----
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.